Microbiological safety of a novel bio-artificial liver support system based on porcine hepatocytes: A experimental study

European Journal of Medical Research

Volumn 17, Issue 1, 2012, Pages

  Han, Bing ^a,b   Shi, Xiao Lei ^a,b   Zhang, Yue ^a,b   Chu, Xue Hui ^a,b   Gu, Jin Yang ^a,b   Xiao, Jiang Qiang ^a   Ren, Hao Zhen ^a   Tan, Jia Jun ^a   Gu, Zhong Ze ^c   Ding, Yi Tao ^a,b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c SOUTHEAST UNIVERSITY   (China)

Author keywords

Bio artificial liver; Mesenchymal stem cells; Microbiological safety; Porcine endogenous retrovirus; Porcine hepatocyte

Indexed keywords

CYTOCHROME B; VIRUS DNA; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOARTIFICIAL LIVER; BIOREACTOR; BLOOD SAMPLING; CELL STRAIN HEK293; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; MESENCHYMAL STEM CELL; MICROBIOLOGICAL PARAMETERS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PORCINE ENDOGENOUS RETROVIRUS; RETROVIRUS; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; VIRUS TRANSMISSION; ANIMAL; ARTIFICIAL LIVER; CLINICAL TRIAL (TOPIC); COCULTURE; DOG; ENDOGENOUS RETROVIRUS; ISOLATION AND PURIFICATION; MESENCHYMAL STROMA CELL; MONONUCLEAR CELL; PATHOGENICITY; SAFETY; VIROLOGY;

ANIMALS; CLINICAL TRIALS AS TOPIC; COCULTURE TECHNIQUES; DOGS; ENDOGENOUS RETROVIRUSES; HEK293 CELLS; HEPATOCYTES; HUMANS; LEUKOCYTES, MONONUCLEAR; LIVER, ARTIFICIAL; MESENCHYMAL STROMAL CELLS; RETROVIRIDAE; SAFETY; SWINE;

EID: 84865783412     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-17-13     Document Type: Article

References (43)

1. Acute liver failure: Summary of a workshop. Lee WM, Squires RH, Nyberg SL, Doo E, Hoofnagle JH, Hepatology 2008 47 4 1401 1415 18318440
2. Perspectives on liver failure: past and future. Riordan SM, Williams R, Semin Liver Dis 2008 28 2 137 141 10.1055/s-2008-1073113 18452113
3. Artificial and bioartificial liver support. McKenzie TJ, Lillegard JB, Nyberg SL, Semin Liver Dis 2008 28 2 210 217 10.1055/s-2008-1073120 18452120
4. Artificial and bioartificial liver devices: present and future. Carpentier B, Gautier A, Legallais C, Gut 2009 58 12 1690 1702 10.1136/gut.2008.175380 19923348
5. Bioartificial liver systems: why, what, whither? Gerlach JC, Zeilinger K, Patzer Ii JF, Regen Med 2008 3 4 575 595 10.2217/17460751.3.4.575 18588477
6. Which are the right cells to be used in a bioartificial liver? Chamuleau RA, Deurholt T, Hoekstra R, Metab Brain Dis 2005 20 4 327 335 10.1007/s11011-005-7914-4 16382343
7. Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Tsiaoussis J, Newsome PN, Nelson LJ, Hayes PC, Plevris JN, Liver Transpl 2001 7 1 2 10 10.1053/jlts.2001.20845 11150414
8. Cell choice for bioartificial livers. Kobayashi N, Okitsu T, Tanaka N, Keio J Med 2003 52 3 151 157 10.2302/kjm.52.151 14529147
9. C-type virus particles in pig kidney cell lines. Armstrong JA, Porterfield JS, De Madrid AT, J Gen Virol 1971 10 2 195 198 10.1099/0022-1317- 10-2-195 4324256
10. Infection of human cells by an endogenous retrovirus of pigs. Patience C, Takeuchi Y, Weiss RA, Nat Med 1997 3 3 282 286 10.1038/nm0397-282 9055854
11. Two sets of human-tropic pig retrovirus. Le Tissier PSJ, Takeuchi Y, Patience C, Weiss RA, Nature 1997 389 6652 681 682 10.1038/39489 9338777
12. Porcine endogenous retroviruses and xenotransplantation. Wilson CA, Cell Mol Life Sci 2008 65 21 3399 3412 10.1007/s00018-008-8498-z 18818871
13. In vitro evaluation of a multi-layer radial-flow bioreactor based on galactosylated chitosan nanofiber scaffolds. Chu XH, Shi XL, Feng ZQ, Gu JY, Xu HY, Zhang Y, Gu ZZ, Ding YT, Biomaterials 2009 30 27 4533 4538 10.1016/j.biomaterials.2009.05.020 19500837
14. Heterotypic interactions in the preservation of morphology and functionality of porcine hepatocytes by bone marrow mesenchymal stem cells in vitro. Gu J, Shi X, Zhang Y, Ding Y, J Cell Physiol 2009 219 1 100 108 10.1002/jcp.21651 19086033
15. Lack of cross-species transmission of porcine endogenous retrovirus in pig-to-baboon xenotransplantation with sustained depletion of anti-alphagal antibodies. Moscoso I, Hermida-Prieto M, Manez R, Lopez-Pelaez E, Centeno A, Diaz TM, Domenech N, Transplantation 2005 79 7 777 782 10.1097/01.TP.0000152662. 55720.83 15818319
16. A polymerase chain reaction-based protocol for the detection of transmission of pig endogenous retroviruses in pig to human xenotransplantation. Blusch JH, Roos C, Nitschko H, Transplantation 2000 69 10 2167 2172 10.1097/00007890-200005270-00036 10852618
17. Design and validation of immunological tests for the detection of Porcine endogenous retrovirus in biological materials. Galbraith DN, Kelly HT, Dyke A, Reid G, Haworth C, Beekman J, Shepherd A, Smith KT, J Virol Methods 2000 90 2 115 124 10.1016/S0166-0934(00)00200-7 11064112
18. No evidence of in vitro and in vivo porcine endogenous retrovirus infection after plasmapheresis through the AMC-bioartificial liver. Di Nicuolo G, van de Kerkhove MP, Hoekstra R, Beld MG, Amoroso P, Battisti S, Starace M, di Florio E, Scuderi V, Scala S, et al. Xenotransplantation 2005 12 4 286 292 10.1111/j.1399-3089.2005.00226.x 15943777
19. Limited infection without evidence of replication by porcine endogenous retrovirus in guinea pigs. Argaw T, Colon-Moran W, Wilson CA, J Gen Virol 2004 85 Pt 1 15 19 14718614
20. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. van der Laan LJ, Lockey C, Griffeth BC, Frasier FS, Wilson CA, Onions DE, Hering BJ, Long Z, Otto E, Torbett BE, et al. Nature 2000 407 6800 90 94 10.1038/35024089 10993079
21. Transmission of porcine endogenous retroviruses in severe combined immunodeficient mice xenotransplanted with fetal porcine pancreatic cells. Deng YM, Tuch BE, Rawlinson WD, Transplantation 2000 70 7 1010 1016 10.1097/00007890-200010150-00004 11045635
22. Microchimerism and transmission of porcine endogenous retrovirus from a pig cell line or specific pathogen-free pig islets to mouse tissues and human cells during xenografts in nude mice. Clemenceau B, Jegou D, Martignat L, Sai P, Diabetologia 2002 45 6 914 923 10.1007/s00125-002-0832-7 12107737
23. Mouse retrovirus mediates porcine endogenous retrovirus transmission into human cells in long-term human-porcine chimeric mice. Yang YG, Wood JC, Lan P, Wilkinson RA, Sykes M, Fishman JA, Patience C, J Clin Invest 2004 114 5 695 700 15343388
24. Pseudotyping of porcine endogenous retrovirus by xenotropic murine leukemia virus in a pig islet xenotransplantation model. Martina Y, Kurian S, Cherqui S, Evanoff G, Wilson C, Salomon DR, Am J Transplant 2005 5 8 1837 1847 10.1111/j.1600-6143.2005.00978.x 15996230
25. Identification of receptors for pig endogenous retrovirus. Ericsson TA, Takeuchi Y, Templin C, Quinn G, Farhadian SF, Wood JC, Oldmixon BA, Suling KM, Ishii JK, Kitagawa Y, et al. Proc Natl Acad Sci U S A 2003 100 11 6759 6764 10.1073/pnas.1138025100 12740431
26. Host range and interference studies of three classes of pig endogenous retrovirus. Takeuchi Y, Patience C, Magre S, Weiss RA, Banerjee PT, Le Tissier P, Stoye JP, J Virol 1998 72 12 9986 9991 9811736
27. Differential resistance to cell entry by porcine endogenous retrovirus subgroup A in rodent species. Mattiuzzo G, Matouskova M, Takeuchi Y, Retrovirology 2007 4 93 10.1186/1742-4690-4-93 18081925
28. Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system. Pitkin Z, Mullon C, Artif Organs 1999 23 9 829 833 10.1046/j.1525-1594.1999.06444.x 10491030
29. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Paradis K, Langford G, Long Z, Heneine W, Sandstrom P, Switzer WM, Chapman LE, Lockey C, Onions D, Otto E, Science 1999 285 5431 1236 1241 10.1126/science.285.5431.1236 10455044
30. Clinical and laboratory evaluation of the safety of a bioartificial liver assist device for potential transmission of porcine endogenous retrovirus. Kuddus R, Patzer JF, Lopez R, Mazariegos GV, Meighen B, Kramer DJ, Rao AS, Transplantation 2002 73 3 420 429 10.1097/00007890-200202150-00017 11884940
31. Bridging a patient with acute liver failure to liver transplantation by the AMC-bioartificial liver. van de Kerkhove MP, Di Florio E, Scuderi V, Mancini A, Belli A, Bracco A, Scala D, Scala S, Zeuli L, Di Nicuolo G, et al. Cell Transplant 2003 12 6 563 568 14579924
32. Long-term absence of porcine endogenous retrovirus infection in chronically immunosuppressed patients after treatment with the porcine cell-based Academic Medical Center bioartificial liver. Di Nicuolo G, DAlessandro A, Andria B, Scuderi V, Scognamiglio M, Tammaro A, Mancini A, Cozzolino S, Di Florio E, Bracco A, et al. Xenotransplantation 2010 17 6 431 439 10.1111/j.1399-3089.2010.00617.x 21158944
33. Porcine endogenous retroviruses: no infection in patients treated with a bioreactor based on porcine liver cells. Irgang M, Sauer IM, Karlas A, Zeilinger K, Gerlach JC, Kurth R, Neuhaus P, Denner J, J Clin Virol 2003 28 2 141 154 10.1016/S1386-6532(02)00275-5 12957184
34. Clinical extracorporeal hybrid liver support-phase I study with primary porcine liver cells. Sauer IM, Kardassis D, Zeillinger K, Pascher A, Gruenwald A, Pless G, Irgang M, Kraemer M, Puhl G, Frank J, et al. Xenotransplantation 2003 10 5 460 469 10.1034/j.1399-3089.2003.00062.x 12950989
35. Characterization of a hollow fiber bioartificial liver device. Abu-Absi SF, Seth G, Narayanan RA, Groehler K, Lai P, Anderson ML, Sielaff T, Hu WS, Artif Organs 2005 29 5 419 422 10.1111/j.1525-1594.2005.29070.x 15854219
36. Detection of PERV by polymerase chain reaction and its safety in bioartificial liver support system. Wang HH, Wang YJ, Liu HL, Liu J, Huang YP, Guo HT, Wang YM, World J Gastroenterol 2006 12 8 1287 1291 16534887
37. Prevalence of porcine endogenous retrovirus in Chinese pig breeds and in patients treated with a porcine liver cell-based bioreactor. Liu Q, Liu Z, Dalakas E, World J Gastroenterol 2005 11 30 4727 4730 16094718
38. No enhanced expression and infectivity of porcine endogenous retrovirus in primary porcine hepatocytes with chitosan nanofiber scaffold. Han B, Shi X, Gu ZZ, Xiao J, Chu X, Gu J, Zhang Y, Tan J, Ding Y, J Biomed Nanotechnol 2011 7 3 377 383 10.1166/jbn.2011.1288 21830478
39. Influence of chitosan nanofiber scaffold on porcine endogenous retroviral expression and infectivity in pig hepatocytes. Han B, Shi XL, Xiao JQ, Zhang Y, Chu XH, Gu JY, Tan JJ, Gu ZZ, Ding YT, World J Gastroenterol 2011 17 22 2774 2780 21734784
40. Polymerase chain reaction assays for the diagnosis of infection with the porcine endogenous retrovirus and the detection of pig cells in human and nonhuman recipients of pig xenografts. Switzer WM, Shanmugam V, Chapman L, Heneine W, Transplantation 1999 68 2 183 188 10.1097/00007890-199907270-00003 10440384
41. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Heneine W, Tibell A, Switzer WM, Sandstrom P, Rosales GV, Mathews A, Korsgren O, Chapman LE, Folks TM, Groth CG, Lancet 1998 352 9129 695 699 10.1016/S0140-6736(98)07145-1 9728986
42. Transfer of porcine endogenous retrovirus across hollow fiber membranes: significance to a bioartificial liver. Nyberg SL, Hibbs JR, Hardin JA, Germer JJ, Persing DH, Transplantation 1999 67 9 1251 1255 10.1097/00007890-199905150- 00009 10342317
43. Influence of human fulminant hepatic failure sera on endogenous retroviral expression in pig hepatocytes. Nyberg SL, Hibbs JR, Hardin JA, Germer JJ, Platt JL, Paya CV, Wiesner RH, Liver Transpl 2000 6 1 76 84 10648582